Liabilities and Equity of Pharma-Bio Serv, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Pharma-Bio Serv, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Pharma-Bio Serv, Inc. Liabilities and Equity for the quarter ending 31 Oct 2025 was $13,653,046, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,653,046 -$2,639,184 -16% 31 Oct 2025 10-K 29 Jan 2026 2025 FY
Q2 2025 $13,585,578 -$2,732,931 -17% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $13,903,541 -$3,021,112 -18% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $16,077,494 -$3,153,752 -16% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $16,292,230 -$3,609,831 -18% 31 Oct 2024 10-K 29 Jan 2026 2025 FY
Q2 2024 $16,318,509 -$3,978,090 -20% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $16,924,653 -$2,693,632 -14% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $19,231,246 -$3,669,164 -16% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $19,902,061 -$748,785 -3.6% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $20,296,599 -$32,246 -0.16% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $19,618,285 -$542,911 -2.7% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $22,900,410 +$826,120 +3.7% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $20,650,846 -$3,270,355 -14% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $20,328,845 -$8,265,787 -29% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $20,161,196 -$7,737,747 -28% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $22,074,290 -$8,124,730 -27% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $23,921,201 -$5,997,545 -20% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $28,594,632 -$1,506,445 -5% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $27,898,943 -$736,980 -2.6% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $30,199,020 +$4,038,775 +15% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $29,918,746 +$3,285,671 +12% 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $30,101,077 +$3,849,995 +15% 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $28,635,923 +$2,981,588 +12% 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $26,160,245 +$877,427 +3.5% 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $26,633,075 +$1,254,763 +4.9% 31 Oct 2019 10-K 01 Feb 2021 2020 FY
Q2 2019 $26,251,082 +$2,944,291 +13% 31 Jul 2019 10-Q 16 Sep 2019 2019 Q3
Q1 2019 $25,654,335 +$3,143,571 +14% 30 Apr 2019 10-Q 14 Jun 2019 2019 Q2
Q4 2018 $25,282,818 +$2,873,382 +13% 31 Jan 2019 10-Q 18 Mar 2019 2019 Q1
Q3 2018 $25,378,312 +$3,028,311 +14% 31 Oct 2018 10-K 29 Jan 2020 2019 FY
Q2 2018 $23,306,791 +$796,570 +3.5% 31 Jul 2018 10-Q 14 Sep 2018 2018 Q3
Q1 2018 $22,510,764 -$52,446 -0.23% 30 Apr 2018 10-Q 14 Jun 2018 2018 Q2
Q4 2017 $22,409,436 -$646,797 -2.8% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q1
Q3 2017 $22,350,001 -$1,647,700 -6.9% 31 Oct 2017 10-K 29 Jan 2019 2018 FY
Q2 2017 $22,510,221 -$1,507,519 -6.3% 31 Jul 2017 10-Q 14 Sep 2017 2017 Q3
Q1 2017 $22,563,210 -$1,649,931 -6.8% 30 Apr 2017 10-Q 14 Jun 2017 2017 Q2
Q4 2016 $23,056,233 -$780,112 -3.3% 31 Jan 2017 10-Q 17 Mar 2017 2017 Q1
Q3 2016 $23,997,701 -$141,205 -0.58% 31 Oct 2016 10-K 29 Jan 2018 2017 FY
Q2 2016 $24,017,740 +$705,753 +3% 31 Jul 2016 10-Q 14 Sep 2016 2016 Q3
Q1 2016 $24,213,141 +$1,120,151 +4.9% 30 Apr 2016 10-Q 14 Jun 2016 2016 Q2
Q4 2015 $23,836,345 +$888,806 +3.9% 31 Jan 2016 10-Q 16 Mar 2016 2016 Q1
Q3 2015 $24,138,906 +$927,822 +4% 31 Oct 2015 10-K 31 Jan 2017 2016 FY
Q2 2015 $23,311,987 +$1,285,082 +5.8% 31 Jul 2015 10-Q 14 Sep 2015 2015 Q3
Q1 2015 $23,092,990 +$1,487,028 +6.9% 30 Apr 2015 10-Q 15 Jun 2015 2015 Q2
Q4 2014 $22,947,539 +$1,869,200 +8.9% 31 Jan 2015 10-Q 17 Mar 2015 2015 Q1
Q3 2014 $23,211,084 +$1,929,148 +9.1% 31 Oct 2014 10-K 29 Jan 2016 2015 FY
Q2 2014 $22,026,905 +$2,920,686 +15% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 $21,605,962 +$3,572,909 +20% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 $21,078,339 +$4,676,061 +29% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $21,281,936 +$5,546,920 +35% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 $19,106,219 +$5,186,492 +37% 31 Jul 2013 10-Q 16 Sep 2013 2013 Q3
Q1 2013 $18,033,053 +$5,520,592 +44% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q2
Q4 2012 $16,402,278 +$4,932,307 +43% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q1
Q3 2012 $15,735,016 +$4,882,817 +45% 31 Oct 2012 10-K 29 Jan 2014 2013 FY
Q2 2012 $13,919,727 +$4,444,225 +47% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 $12,512,461 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 $11,469,971 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 $10,852,199 +$4,294,175 +65% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 $9,475,502 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 $6,558,024 31 Oct 2010 10-K/A 31 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.